MARAVIROC WAYMADE (Waymade Australia Pty Limited)
Product name
MARAVIROC WAYMADE
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
120 (255 working days)
Active ingredients
maraviroc
Registration type
New generic medicine
Indication
Maraviroc Waymade, in combination with other antiretroviral medicinal products, is indicated for adult patients infected with only CCR5-tropic HIV-1.
The use of other active agents with Maraviroc Waymade is associated with a greater likelihood of treatment response.